According to the Society for Assisted Reproductive Technology (SART)’s national data for 2014, our center remains a fertility care and IVF leader in the Mid-Atlantic. More than 45 percent of all fresh in vitro fertilization (IVF) treatment cycles and 51 percent of all babies born from IVF are from successful treatment performed at Shady Grove Fertility. Our center has had more successful IVF cycles and more babies born than the next 20 centers in the Maryland, Pennsylvania, Virginia, and Washington, D.C. region combined.
More Babies Born
SART, whose mission it is to establish and maintain quality standards for assisted reproductive technology (ART), represents more than 90 percent of ART centers in the U.S. and requires uniform annual IVF birth outcome reporting in order that patients can make more informed decisions about their infertility care. For their 2014 National Data Summary, SART culled data from 375 SART-affiliated fertility centers across the U.S.
“At Shady Grove Fertility, one thing we decided long ago was that providing individualized care would be our priority. Despite our size, the number of doctors we have, and our large geographic footprint, we aim to treat each and every patient as if they were our only patient that day. Patients have continually told us that they can feel this personalized level of support while in our care. We’ve been fortunate that our patient satisfaction survey results support this, with 96 percent of our patients saying they would recommend Shady Grove Fertility to a friend or family member,” remarks Michael J. Levy, M.D. Co-founder of Shady Grove Fertility and Director of IVF.
Staying Cutting Edge
In addition to remaining committed to providing personalized care, we also remain committed to ongoing and rigorous research to stay at the cutting edge. In fact, we are one of only a few centers in the nation to employ a full-time dedicated research team and will be presenting data from more than a dozen studies at the October 15-19 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo in Salt Lake City, UT.
“One of the most important advancements in IVF in the last decade has been in oocyte and embryo vitrification, an ultra-rapid cryopreservation technology that allows for safer and more effective freezing. Vitrification now offers patients who find themselves with more embryos than they are able to transfer in a single cycle the option to choose a subsequent frozen embryo transfer (FET) cycle instead of another fresh IVF cycle—effectively resulting in more babies born per oocyte retrieval with less costs and fewer medications,” explains infertility specialist, Eric D. Levens, M.D., of SGF’s Annandale, VA, office.
“Vitrification has also advanced the practice of preimplantation genetic screening (PGS) offering patients the ability to effectively reduce the chances of chromosomal abnormalities and increase the likelihood of a healthy pregnancy,” adds Dr. Levens.
To learn more about our IVF success rates or to schedule an appointment, please call our New Patient Center at 1-877-971-7755.
